<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB"><gtr:id>09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB</gtr:id><gtr:name>University of Rennes 1</gtr:name><gtr:address><gtr:line1>Universite de Rennes 1</gtr:line1><gtr:line2>2 rue du Thabor</gtr:line2><gtr:line3>CS 46510</gtr:line3><gtr:line4>Rennes</gtr:line4><gtr:postCode>35065</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Haematology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB"><gtr:id>09014666-EFE1-4DF4-BDD7-DDE7D8A1AADB</gtr:id><gtr:name>University of Rennes 1</gtr:name><gtr:address><gtr:line1>Universite de Rennes 1</gtr:line1><gtr:line2>2 rue du Thabor</gtr:line2><gtr:line3>CS 46510</gtr:line3><gtr:line4>Rennes</gtr:line4><gtr:postCode>35065</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A"><gtr:id>A15DEEDB-5ADC-4395-A1FD-D7C81690EF3A</gtr:id><gtr:name>Graz University</gtr:name><gtr:address><gtr:line1>Graz University</gtr:line1><gtr:line2>Rechbauerstrasse 12</gtr:line2><gtr:postCode>A-8010</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/61C82DC5-11F2-4E1B-BB86-9A4F479C2095"><gtr:id>61C82DC5-11F2-4E1B-BB86-9A4F479C2095</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Bycroft</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/415F9E79-1641-4793-99E6-05652012FE61"><gtr:id>415F9E79-1641-4793-99E6-05652012FE61</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Warren</gtr:surname><gtr:orcidId>0000-0001-9277-4553</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/44839780-DD6F-4AC5-A446-0BC2CCEA88A2"><gtr:id>44839780-DD6F-4AC5-A446-0BC2CCEA88A2</gtr:id><gtr:firstName>Sjors</gtr:firstName><gtr:otherNames>Hendrik</gtr:otherNames><gtr:surname>Scheres</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FL003368%2F1"><gtr:id>A3C1F67B-D3AB-434E-BB3B-57FE9CBCA3AE</gtr:id><gtr:title>Molecular mechanisms of eukaryotic ribosome biogenesis</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L003368/1</gtr:grantReference><gtr:abstractText>We aim to identify pathways that when perturbed result in the development of life-threatening cancers of the blood such as myelodysplasia and acute leukaemia. Our long term goal is to use this information to design new approaches to the treatment of these devastating cancers of the blood. Recent exciting data link the origins of inherited and acquired forms of blood cancer to defects in so-called &amp;quot;housekeeping&amp;quot; processes in our cells, specifically in the assembly of the machines (called ribosomes) that make proteins. A major focus of our work is to understand in detail how ribosomes are put together from their component parts. To do this, we are learning about the three-dimensional shape of some of the key proteins involved and trying to undersrand how these proteins work together to assemble mature ribosomes. In addition to experiments in the test tube, we are also using a range of model organisms to determine the role of specific ribosome assembly factors in living cells. The fundamental insights that we hope to obtain will not only provide a deeper understanding of the fundamental mechanisms underlying the process of ribosome assembly, but will also help improve the diagnosis and long-term outlook for patients affected by disorders of ribosome synthesis and, more generally, for patients affected by cancer.</gtr:abstractText><gtr:technicalSummary>Ribosome assembly is an essential, highly conserved process that is tightly coupled to cell growth and proliferation. However, the molecular mechanism underlying this process remains poorly understood. Excitingly, a new class of cancer predisposition syndromes collectively called the &amp;quot;ribosomopathies&amp;quot; has recently emerged that harbour mutations in components of the ribosome assembly pathway that are shedding new light on this process. In particular, we have discovered that the SBDS protein that is deficient in the leukaemia predisposition disorder Shwachman-Diamond syndrome is required for maturation of the large ribosomal subunit. SBDS controls the translational activation of ribosomes by catalysing dissociation of the anti-association factor eIF6 from nascent 60S subunits, but the precise mechanism remains unclear. We propose a model in which GTP-dependent conformational change in elongation factor-like 1 (EFL1) induces an inter-domain rotation in SBDS that directly or indirectly triggers eIF6 release. We aim to test this hypothesis at the molecular level by combining the latest advances in single-particle cryo-electron microscopy and NMR spectroscopy with X-ray crystallography, biochemistry and innovative genetic platforms. We will test the hypothesis that eIF6 release is a prerequisite for eviction of additional assembly factors whose specific role in ribosome assembly we will determine. Novel insights into the mechanisms of ribosome assembly are not only exploitable for the design of targeted therapeutics for the ribosomopathies, but also for cancer drug discovery more generally.</gtr:technicalSummary><gtr:potentialImpactText>This research project has been designed to have an impact beyond the academic environment. Our work will benefit many stakeholders in the rare disease community including patients, patient's representatives, health care professionals, industry, policymakers and representatives of Members States of the European Organisation for Rare Diseases (EURORDIS). There are 30 million people affected by rare disorders in the EU, and all of these patients face the same problems of lack of access to information, to diagnosis, to care, to drugs and to appropriate support. By increasing awareness of the pathophysiology of rare diseases and drawing molecular links between them, our work will help promote the extension of new policy on rare disease internationally to enhance the development of new drugs and optimise access to health care. Indeed, the Shwachman-Diamond Syndrome (SDS) Foundation in the USA is actively promoting fund-raising and sponsorship to develop new treatments for this condition based on the findings emerging from our work. 
Advances in our basic understanding of bone marrow failure will benefit patients, their families, their physicians, nurses, dieticians and clinical psychologists. Greater understanding of disease pathogenesis and the consequences of disease mutations in SDS helps patients and their families come to terms with their disease. Patients will also benefit by reconfiguration of the commissioning of health care provision in the UK to National Centres of Excellence, thereby increasing the referral base, and enhancing physician expertise in managing the multidisciplinary problems with which these patients present. This will benefit Addenbrookes NHS Trust by further raising its clinical profile and bringing in more resource to treat the increased number of specialist referrals.
The work will benefit clinicians who manage patients with bone marrow failure disorders and myelodysplastic syndrome by educating them in disease pathophysiology. They will pass the new insights on to their patients and colleagues. By elucidating the molecular basis of rare diseases, new links will be established between clinicians and basic scientists working in previously diverse fields.
The research will enhance the training and education of students and clinical fellows.
The general public will benefit from dissemination of our research findings as they will appreciate that advances in societal health and well being are the product of a culture that supports a strong science base and will further support investment in research.
Schoolchildren will benefit from the research by understanding more about science and its value. As a well-supported and successful science lab, we are better able to communicate our exciting ideas and to stimulate schoolchildren to consider research careers.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2014-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1618490</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Graz</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Institute of Molecular Biosciences</gtr:department><gtr:description>ribosome assembly mechanisms</gtr:description><gtr:id>D6228C63-249B-400B-87F6-7421E94E03AD</gtr:id><gtr:impact>Invited plenary talk at the Austrian biochemical society</gtr:impact><gtr:outcomeId>56d08483d0e4c6.25098661-1</gtr:outcomeId><gtr:partnerContribution>Purification of 60S pre-ribosome particles</gtr:partnerContribution><gtr:piContribution>We are performing cryo-EM reconstructions of 60S pre-ribosome particles</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Dictyostelium ribosomes by cryo-EM</gtr:description><gtr:id>666447EA-9FD5-480A-9B0D-5B8B646A43F9</gtr:id><gtr:impact>Weis F, Giudice E, Churcher M, Jin L, Li Jin, Hilcenko C, Wong CC, Traynor D, Kay RR, Warren AJ. Preparing the 60S ribosomal subunit for translation: structural basis of eIF6 release (revision submitted).</gtr:impact><gtr:outcomeId>54492d86b8a207.50642797-1</gtr:outcomeId><gtr:partnerContribution>Culture of Dictyostelium discoideum cells</gtr:partnerContribution><gtr:piContribution>Resulted in submission of a scientific manuscript</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rennes 1 (Universit? de Rennes 1)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>cryo-electron microscopy model building</gtr:description><gtr:id>68626F40-4DA1-4F8D-817E-51A47FD08443</gtr:id><gtr:impact>Weis F, Giudice E, Churcher M, Jin L, Hilcenko C, Wong CC, Traynor D, Kay RR, Warren AJ. Mechanism of eIF6 release from the nascent 60S ribosomal subunit. Nat Struct Mol Biol, (2015) doi:10.1038/nsmb.3112, PMID: 26479198. Accompanying News and Views.</gtr:impact><gtr:outcomeId>563a44fb54fab5.08585533-1</gtr:outcomeId><gtr:partnerContribution>Emmanuel performed model building of RNA and protein in cryo-EM maps.</gtr:partnerContribution><gtr:piContribution>Generating cryo-EM maps, biochemical and genetic data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E65AA37D-1E25-487B-AE46-F3C0E40E4846</gtr:id><gtr:impact>Presentation at international meeting sparking questions and discussion afterwards

Invitations to visit new international collaborators</gtr:impact><gtr:outcomeId>544933d362d8c2.39548434</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8DC719B-F032-497E-AA0C-DC4E42517D9A</gtr:id><gtr:impact>7th SDS International Conference, Toronto, Canada, November 2013
Talk was delivered by myself and was entitled &amp;quot;Function of the SBDS protein in ribosome biogenesis&amp;quot;.

Galvanised discussion about moving forwards to drug development for this disease.</gtr:impact><gtr:outcomeId>ZgfiLuwSAM5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.cepd.utoronto.ca/sds/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>American Society of Haematology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>19077122-E32F-4EB9-9A70-03A1C0713A22</gtr:id><gtr:impact>A formal presentation was followed by a separate round table discussion session by the 3 presenters at the scientific session driven by questions by an audience of around 30 people.</gtr:impact><gtr:outcomeId>589a63bec89b66.55837876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>invited talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>031782D5-6FDE-4A16-94C6-73543951F6D7</gtr:id><gtr:impact>Presented latest research findings. Work was also awarded a best poster prize.</gtr:impact><gtr:outcomeId>56d085aa3bd739.04585641</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0A6E4147-CBC1-4859-BCE7-AEABB1528877</gtr:id><gtr:impact>Raised awareness of the mechanisms of disease to a wide audience of patients and members of the general public

I was contacted by patient groups who want to publicise the work on their websites</gtr:impact><gtr:outcomeId>563a4a214e00d2.83429809</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L003368/1</gtr:fundingRef><gtr:id>6E53C477-B4A2-4B45-98D0-B50B688D72DD</gtr:id><gtr:outcomeId>LGv2bBCVzVC</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defective ribosome assembly in leukaemia</gtr:description><gtr:end>2021-03-02</gtr:end><gtr:fundingOrg>Bloodwise</gtr:fundingOrg><gtr:id>23D22778-4457-4441-A259-1A5DC5B49510</gtr:id><gtr:outcomeId>563a45ee0875a9.44428152</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>76E192BA-81AF-47CE-99A7-EA8BEBAE021A</gtr:id><gtr:title>Congenital and Acquired Bone Marrow Failure</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94d4aae24b47e0032ae580c80d958a9e"><gtr:id>94d4aae24b47e0032ae580c80d958a9e</gtr:id><gtr:otherNames>Warren A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:isbn>0128041757, 9780128041758</gtr:isbn><gtr:outcomeId>589a5fed7192b1.31686482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C2F8C2E-9B03-4798-86BC-7DDB27996039</gtr:id><gtr:title>Binding of the integrated stress response inhibitor, ISRIB, reveals a regulatory site in the nucleotide exchange factor, eIF2B</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bdbb1af67d1701239d1c9a788ed30df1"><gtr:id>bdbb1af67d1701239d1c9a788ed30df1</gtr:id><gtr:otherNames>Zyryanova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a93ffd6db6cf0.85497427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60DDD0F2-35B8-4B2D-BD67-B69D477A192D</gtr:id><gtr:title>Mechanism of eIF6 release from the nascent 60S ribosomal subunit.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5aa4a10057d5e31aa761e4feb9adc665"><gtr:id>5aa4a10057d5e31aa761e4feb9adc665</gtr:id><gtr:otherNames>Weis F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>563a43736b2578.28471598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C725870-2ACE-4208-BB18-8E10FE1FDC99</gtr:id><gtr:title>Decoding erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ccfdccfee9f5c568275cd5a6d39dd3"><gtr:id>83ccfdccfee9f5c568275cd5a6d39dd3</gtr:id><gtr:otherNames>Warren AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>589a5dd37384f1.96326294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E980975B-E516-48D5-9A56-B59819864253</gtr:id><gtr:title>A new system for naming ribosomal proteins.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad4031ae76ee267f2e53214696773721"><gtr:id>ad4031ae76ee267f2e53214696773721</gtr:id><gtr:otherNames>Ban N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>585d52170d1074.71084808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A19A5253-8031-4EAD-AE00-72108A457BF7</gtr:id><gtr:title>The Ribosome Biogenesis Protein Nol9 Is Essential for Definitive Hematopoiesis and Pancreas Morphogenesis in Zebrafish.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2070899bdb913e4773c2e6617fa222dc"><gtr:id>2070899bdb913e4773c2e6617fa222dc</gtr:id><gtr:otherNames>Bielczyk-Maczynska E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56d0832784a730.22244141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20B68BB5-54C6-453A-B66B-31364A633B55</gtr:id><gtr:title>Shwachman-Bodian-Diamond syndrome (SBDS) protein deficiency impairs translation re-initiation from C/EBPa and C/EBP? mRNAs.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c07676d30083786c312a215caf037d6"><gtr:id>8c07676d30083786c312a215caf037d6</gtr:id><gtr:otherNames>In K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56d08327c7a566.30181691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>134C29AA-2FDF-437D-B9D1-B1EEBD940575</gtr:id><gtr:title>Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46876f4e7c662ddb25c33f54fe22f57d"><gtr:id>46876f4e7c662ddb25c33f54fe22f57d</gtr:id><gtr:otherNames>McKerrell T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>585d6b2f865ba1.02465445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36E3D24D-4B13-4291-8B63-CADF3E75D421</gtr:id><gtr:title>Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome.</gtr:title><gtr:parentPublicationTitle>Advances in biological regulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83ccfdccfee9f5c568275cd5a6d39dd3"><gtr:id>83ccfdccfee9f5c568275cd5a6d39dd3</gtr:id><gtr:otherNames>Warren AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2212-4926</gtr:issn><gtr:outcomeId>5a616e669dc1e2.77510366</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L003368/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>78FE8F42-8AFB-48F8-8662-37D541AD95BF</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Congenital Disorders</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>